We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.54B
(+14%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$798M |
| 2 |
ExxonMobil
XOM
|
+$189M |
| 3 |
Cognizant
CTSH
|
+$86.4M |
| 4 |
Merck
MRK
|
+$80.6M |
| 5 |
Integra LifeSciences
IART
|
+$47.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$57.5M |
| 2 |
PepsiCo
PEP
|
+$55.1M |
| 3 |
Dollar General
DG
|
+$49.7M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$48.1M |
| 5 |
Simon Property Group
SPG
|
+$45.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.52% |
| 2 | Technology | 14.11% |
| 3 | Financials | 12.07% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
East-West Bancorp
EWBC
$17.9B
| $3.02M | 0.01% |
58,512
-3,338
| -5% | -$175K |
|
|
CS
502
DELISTED
Credit Suisse Group
CS
| $3.02M | 0.01% |
203,459
+195,832
| +2,568% | +$2.99M |
|
|
EQM
503
DELISTED
EQM Midstream Partners, LP
EQM
| $3.02M | 0.01% |
39,250
-5,775
| -13% | -$451K |
|
504
Best Buy
BBY
$18B
| $2.99M | 0.01% |
60,864
+59,936
| +6,459% | +$2.68M |
|
505
Fortive
FTV
$19B
| $2.99M | 0.01% |
78,763
-1,275
| -2% | -$45.7K |
|
|
SCLN
506
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $2.99M | 0.01% |
305,073
| – | – |
|
507
State Street
STT
$50.9B
| $2.98M | 0.01% |
37,491
+718
| +2% | +$56.9K |
|
|
CVG
508
DELISTED
Convergys
CVG
| $2.94M | 0.01% |
139,295
+48,820
| +54% | +$1.15M |
|
509
CNA Financial
CNA
$14.5B
| $2.92M | 0.01% |
66,100
| – | – |
|
|
BHI
510
DELISTED
Baker Hughes
BHI
| $2.92M | 0.01% |
48,804
+1,074
| +2% | +$65.4K |
|
511
Bunge Global
BG
$23.6B
| $2.92M | 0.01% |
36,837
+19,557
| +113% | +$1.47M |
|
512
C.H. Robinson
CHRW
$22B
| $2.92M | 0.01% |
37,738
+721
| +2% | +$55.4K |
|
513
Vanguard Large-Cap ETF
VV
$51.9B
| $2.9M | 0.01% |
26,825
-900
| -3% | -$95.9K |
|
514
iShares MSCI EAFE Growth ETF
EFG
$16.3B
| $2.9M | 0.01% |
41,672
-3,161
| -7% | -$212K |
|
515
MetLife
MET
$61B
| $2.89M | 0.01% |
61,382
-136,006
| -69% | -$6.48M |
|
516
Morgan Stanley
MS
$337B
| $2.88M | 0.01% |
67,359
+429
| +0.6% | +$19K |
|
517
Devon Energy
DVN
$51.9B
| $2.85M | 0.01% |
68,450
+22,755
| +50% | +$1M |
|
518
Universal Health Services
UHS
$9.43B
| $2.84M | 0.01% |
22,822
+10,780
| +90% | +$1.27M |
|
|
LHO
519
DELISTED
LaSalle Hotel Properties
LHO
| $2.84M | 0.01% |
97,977
+97,860
| +83,641% | +$2.91M |
|
520
Genpact
G
$5.3B
| $2.83M | 0.01% |
114,427
+291
| +0.3% | +$7.09K |
|
521
American Airlines Group
AAL
$9.58B
| $2.8M | 0.01% |
66,321
-2,685
| -4% | -$121K |
|
522
iShares S&P 500 Growth ETF
IVW
$72.5B
| $2.8M | 0.01% |
85,220
+200
| +0.2% | +$6.42K |
|
523
Nabors Industries
NBR
$1.23B
| $2.77M | 0.01% |
4,244
+5
| +0.1% | +$3.83K |
|
|
WP
524
DELISTED
Worldpay, Inc.
WP
| $2.74M | 0.01% |
42,794
-3,543
| -8% | -$225K |
|
525
Vanguard Mid-Cap ETF
VO
$106B
| $2.7M | 0.01% |
77,592
-6,060
| -7% | -$208K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.
- Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
- Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
- Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
- Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
- Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
- Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
- Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.
Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.